Tobacco Control and Smoking Cessation Committee

Improving patient care by raising awareness of cessation-related data and by provision of information regarding the latest and most successful cessation techniques for patients with lung cancer.
Committees_Tobacco_NEW banner_Stock_hero

Overview

It is well known that ongoing tobacco use is associated with poorer survival in patients with cancer. This committee works to provide lung cancer care providers with tools to reinforce tobacco assessment and enhance cessation support. From recommendations for global governments to toolkits for care providers, the Tobacco Control and Smoking Cessation Committee is active and engaged at all levels.

Chair of Committee

Bill Evans
Bill Evans
2021 to present

IASLC Position Statement on Tobacco Cessation After a Cancer Diagnosis

Tobacco use is a well-established cause of cancer and contributes to about 1 in 3 cancer deaths. Whereas the harmful effects of smoking on health are well recognized, the negative impacts of continued smoking after a diagnosis of cancer are under appreciated. The substantial body of research reviewed in the 2014 US Surgeon General’s Report concluded that smoking by cancer patients and survivors causes adverse outcomes, including increased overall mortality and cancer-related mortality, greater risk of a second primary cancer, and associations with substantially worse toxicity from cancer treatments. The clinical effects of smoking after a diagnosis of cancer also substantially increase the cost of cancer care. The 2020 US Surgeon General’s Report reported that smoking cessation after a cancer diagnosis is associated with improved survival, and quitting smoking provides significant benefits for non-cancer-related health outcomes. The recommendations are available in English, Spanish, Portugese, Japanese, Chinese, and Polish.

Roster

Bill Evans
Canada
McMaster University
Committee Chair
Matthew Steliga
United States
University of Arkansas
Past Chair
Carlos Gil Moreira Ferreira
Brazil
Oncoclinicas Institute
Board Liaison
Katie Maher
United States
International Association for the Study of Lung Cancer
Staff Liaison
Douglas Arenberg
United States
University of Michigan
Committee Member
Deepti Behl
United States
Sutter Health
Committee Member
Eric Bernicker
United States
The Methodist Hospital
Committee Member
Wanda de kanter
Netherlands
The Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital
Committee Member
Carolyn Dresler
United States
Center for Tobacco Products USA FDA
Committee Member
Lawson Eng
Canada
Princess Margaret Cancer Centre
Committee Member
Babalola Faseru
United States
University of Kansas Medical Center
Committee Member
Joelle Fathi
United States
University of Washington
Committee Member
Maciej Goniewicz
United States
Roswell Park Cancer Institute
Committee Member
Jacek Jassem
Poland
Medical University of Gdansk
Committee Member
James Jett
United States
Oncimmune Ltd
Committee Member
Laura McHugh
United States
Baptist Cancer Center
Committee Member
Deebya Mishra
Nepal
B P Koirala Institute of Health Sciences
Committee Member
Emma O'Dowd
United Kingdom
University of Nottingham
Committee Member
Abhishek Shankar
India
All India Institute of Medical Sciences (AIIMS)
Committee Member
Conor Steuer
United States
Emory University
Committee Member
Emily Stone
Australia
St Vincent's Hospital Sydney
Committee Member
Graham Warren
United States
Medical University of South Carolina
Committee Member
Nise Yamaguchi
Brazil
Hospital Israelita Albert Einstein
Committee Member